LTBR CEO Seth Grae Exercises 7,616 Options, Sells Shares at $25.84
Rhea-AI Filing Summary
Director and CEO Seth Grae reported exercising 7,616 employee stock options on 10/10/2025 and immediately selling the same 7,616 shares. The option exercise used a $10.80 exercise price for those options and the subsequent sale generated a weighted average sale price of $25.84 per share, with trade prices reported between $25.80 and $25.92. The transactions were executed under a Rule 10b5-1 trading plan adopted on 09/12/2024, which the filer discloses as the basis for the timing. Following these transactions, the reporting person beneficially owned 760,932 shares before the sale and 753,316 shares after the sale. The filing also lists outstanding employee stock options exercisable at $12.60, $18.48, and $55.20 with various exercisability and expiration dates.
Positive
- Transparent disclosure of exercises and sales under a Rule 10b5-1 plan adopted on 09/12/2024
- Realized gain on exercised options: exercise at $10.80 vs weighted sale at $25.84 for 7,616 shares
Negative
- Insider share count reduced from 760,932 to 753,316 following the sale
- Potential future dilution from outstanding options (examples include $12.60, $18.48, and $55.20 strikes)
Insights
Insider exercised vested options and sold the same shares under a pre-existing 10b5-1 plan.
The reporting person, who serves as President and CEO, exercised 7,616 options at an exercise price of $10.80 on 10/10/2025 and sold the resulting shares at a weighted average of $25.84. The filing states these trades were made pursuant to a Rule 10b5-1 plan adopted on 09/12/2024, which is a standard mechanism to provide an affirmative defense against insider trading claims when properly structured.
The key dependencies are the 10b5-1 plan's terms and whether sales follow its predetermined schedule; investors can monitor subsequent Form 4s for further planned trades or departures from the plan. Near-term items to watch include any additional option exercises or open-market sales by executives reported on future filing dates.
Transaction reduces option-held position by exercising vested options and realizes spread between exercise and sale price.
The exercised options had an exercise price of $10.80, and the shares were sold at an average of $25.84, realizing a pre-tax spread of about $15.04 per share on those 7,616 shares. The Form 4 also records additional vested and unvested employee stock options totaling ~76,062 underlying shares across listed grants.
Risk factors include potential dilution if remaining options are exercised; monitor option exercise schedules and expiration dates listed (for example expirations through 08/06/2028) for future dilution timing and any patterned sales under the 10b5-1 plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 7,616 | $0.00 | -- |
| Exercise | Common Stock | 7,616 | $10.80 | $82K |
| Sale | Common Stock | 7,616 | $25.84 | $197K |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
Footnotes (1)
- The reported exercise of 7,616 employee stock options and sale of 7,616 shares of common stock were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.80 to $25.92, inclusive. The reporting person undertakes to provide to Lightbridge Corporation, any security holder of Lightbridge Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. This option is fully vested as of the date of this report.
